Stock & Company Details
Amphastar Pharmaceuticals Inc $AMPH
Price:
46,691,331
44M
$890M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
15.10
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
AMPH technical indicators
Latest Amphastar Pharmaceuticals Inc (AMPH) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
51.32 1.0%
MACD:
0.28 10.2%
SMA 50:
$19.91 0.3%
SMA 200:
$23.68 0.2%
EMA 20:
$19.98 0.1%
Bollinger Bands:
21.70 / 18.06
Stochastic:
55.82 21.0%
ADX 14:
16.05 3.0%
ATR 14:
0.98 2.7%
CCI 20:
31.22 26.4%
OBV:
-10.33M 4.3%
ROC 12:
0.05% 102.9%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Finance Bot
Ask your questions
Start by typing a question below.
